Systemic	systemic	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
and	and	O	O	O	O
resuscitation	resuscitation	O	O	O	O
in	in	O	O	O	O
bupivacaine-	bupivacaine-	O	O	O	O
,	,	O	O	O	O
levobupivacaine-	levobupivacaine-	O	O	O	O
,	,	O	O	O	O
or	or	O	O	O	O
ropivacaine-infused	ropivacaine-infused	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
compared	compared	O	O	O	O
the	the	O	O	O	O
systemic	systemic	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
of	of	O	O	O	O
bupivacaine	bupivacaine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
levobupivacaine	levobupivacaine	O	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
ropivacaine	ropivacaine	O	O	OTHERS	I
in	in	O	O	O	O
anesthetized	anesthetized	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
also	also	O	O	O	O
compared	compared	O	O	O	O
the	the	O	O	O	O
ability	ability	O	O	O	O
to	to	O	O	O	O
resuscitate	resuscitate	O	O	O	O
rats	rats	O	O	O	O
after	after	O	O	O	O
lethal	lethal	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
local	local	O	O	O	O
anesthetics	anesthetics	O	O	O	O
.	.	O	O	O	O

Bupivacaine	bupivacaine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
levobupivacaine	levobupivacaine	O	O	OTHERS	I
,	,	O	O	O	O
or	or	O	O	O	O
ropivacaine	ropivacaine	O	O	OTHERS	I
was	was	O	O	O	O
infused	infused	O	O	O	O
at	at	O	O	O	O
a	a	O	O	O	O
rate	rate	O	O	O	O
of	of	O	O	O	O
2	2	O	O	O	O
mg	mg	O	O	OTHERS	I
.	.	O	O	O	O

kg(-1	kg(-1	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

min(-1	min(-1	O	O	O	O
)	)	O	O	O	O
while	while	O	O	O	O
electrocardiogram	electrocardiogram	O	O	O	O
,	,	O	O	O	O
electroencephalogram	electroencephalogram	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
arterial	arterial	O	O	O	O
pressure	pressure	O	O	O	O
were	were	O	O	O	O
continuously	continuously	O	O	O	O
monitored	monitored	O	O	O	O
.	.	O	O	O	O

When	when	O	O	O	O
asystole	asystole	O	DISEASE	OTHERS	I
was	was	O	O	O	O
recorded	recorded	O	O	O	O
,	,	O	O	O	O
drug	drug	O	O	O	O
infusion	infusion	O	O	O	O
was	was	O	O	O	O
stopped	stopped	O	O	O	O
and	and	O	O	O	O
a	a	O	O	O	O
resuscitation	resuscitation	O	O	O	O
sequence	sequence	O	O	O	O
was	was	O	O	O	O
begun	begun	O	O	O	O
.	.	O	O	O	O

Epinephrine	epinephrine	CHEMICALS	O	OTHERS	I
0.01	0.01	O	O	O	O
mg/kg	mg/kg	O	O	O	O
was	was	O	O	O	O
administered	administered	O	O	O	O
at	at	O	O	O	O
1-min	1-min	O	O	O	O
intervals	intervals	O	O	O	O
while	while	O	O	O	O
external	external	O	O	O	O
cardiac	cardiac	O	O	O	O
compressions	compressions	O	O	O	O
were	were	O	O	O	O
applied	applied	O	O	O	O
.	.	O	O	O	O

Resuscitation	resuscitation	O	O	O	O
was	was	O	O	O	O
considered	considered	O	O	O	O
successful	successful	O	O	O	O
when	when	O	O	O	O
a	a	O	O	O	O
systolic	systolic	O	O	O	O
arterial	arterial	O	O	O	O
pressure	pressure	O	O	O	O
>	>	O	O	O	O
or	or	O	O	O	O
=	=	O	O	O	O
100	100	O	O	O	O
mm	mm	O	O	OTHERS	I
Hg	hg	O	O	OTHERS	I
was	was	O	O	O	O
achieved	achieved	O	O	O	O
within	within	O	O	O	O
5	5	O	O	O	O
min	min	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
cumulative	cumulative	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
levobupivacaine	levobupivacaine	O	O	OTHERS	I
and	and	O	O	O	O
ropivacaine	ropivacaine	O	O	OTHERS	I
that	that	O	O	O	O
produced	produced	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
were	were	O	O	O	O
similar	similar	O	O	O	O
and	and	O	O	O	O
were	were	O	O	O	O
larger	larger	O	O	O	O
than	than	O	O	O	O
those	those	O	O	O	O
of	of	O	O	O	O
bupivacaine	bupivacaine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
cumulative	cumulative	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
levobupivacaine	levobupivacaine	O	O	OTHERS	I
that	that	O	O	O	O
produced	produced	O	O	O	O
dysrhythmias	dysrhythmias	O	O	OTHERS	I
and	and	O	O	O	O
asystole	asystole	O	DISEASE	OTHERS	I
were	were	O	O	O	O
smaller	smaller	O	O	O	O
than	than	O	O	O	O
the	the	O	O	O	O
corresponding	corresponding	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
ropivacaine	ropivacaine	O	O	OTHERS	I
,	,	O	O	O	O
but	but	O	O	O	O
they	they	O	O	O	O
were	were	O	O	O	O
larger	larger	O	O	O	O
than	than	O	O	O	O
those	those	O	O	O	O
of	of	O	O	O	O
bupivacaine	bupivacaine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
number	number	O	O	O	O
of	of	O	O	O	O
successful	successful	O	O	O	O
resuscitations	resuscitations	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
differ	differ	O	O	O	O
among	among	O	O	O	O
groups	groups	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
smaller	smaller	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
epinephrine	epinephrine	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
required	required	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
Ropivacaine	ropivacaine	O	O	OTHERS	I
group	group	O	O	O	O
than	than	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
other	other	O	O	O	O
groups	groups	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
conclude	conclude	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
systemic	systemic	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
of	of	O	O	O	O
levobupivacaine	levobupivacaine	O	O	OTHERS	I
is	is	O	O	O	O
intermediate	intermediate	O	O	O	O
between	between	O	O	O	O
that	that	O	O	O	O
of	of	O	O	O	O
ropivacaine	ropivacaine	O	O	OTHERS	I
and	and	O	O	O	O
bupivacaine	bupivacaine	CHEMICALS	O	OTHERS	I
when	when	O	O	O	O
administered	administered	O	O	O	O
at	at	O	O	O	O
the	the	O	O	O	O
same	same	O	O	O	O
rate	rate	O	O	O	O
and	and	O	O	O	O
that	that	O	O	O	O
ropivacaine-induced	ropivacaine-induced	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
arrest	arrest	O	DISEASE	OTHERS	I
appears	appears	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
more	more	O	O	O	O
susceptible	susceptible	O	O	O	O
to	to	O	O	O	O
treatment	treatment	O	O	O	O
than	than	O	O	O	O
that	that	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
bupivacaine	bupivacaine	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
levobupivacaine	levobupivacaine	O	O	OTHERS	I
.	.	O	O	O	O

